Legal & General Group PLC Adma Biologics, Inc. Transaction History

Legal & General Group PLC

$470 Billion
Q3 2024

A detailed history of Legal & General Group PLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 697,010 shares of ADMA stock, worth $12.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

697,010

Previous 697,010 -0.0%

Holding current value

$12.2 Million

Previous $13.9 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$11.21 - $20.03 $4.92 Million - $8.78 Million	438,527 Added 169.65%	697,010 $13.9 Million
Q2 2024 Aug 14, 2024	BUY	$5.98 - $11.18 $209,760 - $392,160	35,077 Added 15.7%	258,483 $2.89 Million
Q1 2024 Jul 01, 2024	BUY	$4.4 - $6.74 $38,926 - $59,628	8,847 Added 4.12%	223,406 $1.47 Million
Q1 2024 May 14, 2024	BUY	$4.4 - $6.74 $145,983 - $223,619	33,178 Added 18.29%	214,559 $1.42 Million
Q4 2023 Feb 15, 2024	BUY	$3.08 - $4.52 $15,018 - $22,039	4,876 Added 2.76%	181,381 $819,000
Q3 2023 Nov 14, 2023	BUY	$3.47 - $4.61 $51,571 - $68,513	14,862 Added 9.19%	176,505 $631,000
Q2 2023 Aug 14, 2023	BUY	$3.12 - $4.22 $263,842 - $356,864	84,565 Added 109.71%	161,643 $596,000
Q1 2023 May 15, 2023	BUY	$3.01 - $3.87 $23,727 - $30,507	7,883 Added 11.39%	77,078 $255,000
Q4 2022 Feb 14, 2023	BUY	$2.47 - $3.88 $122,813 - $192,921	49,722 Added 255.34%	69,195 $268,000
Q3 2022 Nov 14, 2022	SELL	$2.03 - $2.86 $14,853 - $20,926	-7,317 Reduced 27.31%	19,473 $47,000
Q2 2022 Aug 22, 2022	BUY	$1.43 - $2.2 $38,309 - $58,938	26,790 New	26,790 $53,000
Q2 2021 Aug 12, 2021	SELL	$1.51 - $2.07 $10,665 - $14,620	-7,063 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$2.04 - $3.74 $6,929 - $12,704	-3,397 Reduced 32.48%	7,063 $17,000
Q1 2020 May 14, 2020	BUY	$1.5 - $4.59 $502 - $1,537	335 Added 3.31%	10,460 $30,000
Q4 2019 Feb 13, 2020	BUY	$3.89 - $5.15 $6,799 - $9,002	1,748 Added 20.87%	10,125 $41,000
Q3 2019 Nov 13, 2019	BUY	$3.19 - $5.39 $10,724 - $18,121	3,362 Added 67.04%	8,377 $37,000
Q2 2019 Aug 14, 2019	BUY	$3.52 - $5.24 $7,758 - $11,548	2,204 Added 78.41%	5,015 $19,000
Q2 2018 Aug 10, 2018	BUY	$4.39 - $5.44 $12,340 - $15,291	2,811 New	2,811 $13,000

Others Institutions Holding ADMA

# of Institutions

319

Shares Held

184M

Call Options Held

917K

Put Options Held

91.6K

View Full List

About ADMA BIOLOGICS, INC.

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.43B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

More about ADMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Adma Biologics, Inc. Transaction History